Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
2.540
-0.040 (-1.55%)
At close: May 12, 2025, 4:00 PM
2.610
+0.070 (2.76%)
After-hours: May 12, 2025, 5:18 PM EDT
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $2.37 million as of May 12, 2025. Its market cap has increased by 39.50% in one year.
Market Cap
2.37M
Enterprise Value
2.49M
1-Year Change
39.50%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $2.37M, a decrease of -78.83%. That is a compound annual growth rate of -14.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 2.20M | -24.14% |
Dec 31, 2024 | 2.90M | 31.82% |
Dec 29, 2023 | 2.20M | -60.00% |
Dec 30, 2022 | 5.50M | -83.68% |
Dec 31, 2021 | 33.70M | 5.64% |
Dec 31, 2020 | 31.90M | -65.85% |
Dec 31, 2019 | 93.40M | 199.36% |
Dec 31, 2018 | 31.20M | 72.38% |
Dec 29, 2017 | 18.10M | 60.18% |
Dec 30, 2016 | 11.30M | 0.89% |
Dec 31, 2015 | 11.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |